Journals / Turkish Journal of Veterinary and Animal Sciences / 2016 / Cilt: 40 - Sayı: 2

High level fluoroquinolone resistance in Escherichia coli isolatedfrom animals in Turkey is due to multiple mechanisms

Pages
214–218
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The results of this study show a wide range of different mechanisms of fluoroquinolone resistance in E. coli isolates in Turkey.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study was to determine the molecular mechanisms of fluoroquinolone resistance in E. coli isolated from cattle, goats, sheep, cats, and dogs in Turkey.
📊
Key Findings & Data:To identify phenotypic differences between isolates, the sum of the MIC values of 14 antimicrobials was calculated; values ranged from 565 to 2520 μg/mL, indicating the diversity in antimicrobial resistance present in the panel of isolates.
💡
Conclusion & Impact:The results of this study show a wide range of different mechanisms of fluoroquinolone resistance in E. coli isolates in Turkey.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of this study was to determine the molecular mechanisms of fluoroquinolone resistance in E. coli isolated from cattle, goats, sheep, cats, and dogs in Turkey. Twenty nonreplicate E. coli isolates (chosen on the basis of RAPD pattern) from food-producing animals were selected for the study. To identify phenotypic differences between isolates, the sum of the MIC values of 14 antimicrobials was calculated; values ranged from 565 to 2520 μg/mL, indicating the diversity in antimicrobial resistance present in the panel of isolates. PCR and qRT-PCR were used to characterize the presence and expression levels of known molecular mechanisms of fluoroquinolone resistance. The number of E. coli isolates having single, double, and triple topoisomerase mutations was 2, 10, and 5, respectively. Moreover, the number of qnrA - , qnrS - , oqxB -, and aac(6 )Ib-cr-containing E. coli isolates was 1, 4, 1, and 17, respectively. Increased expression of acrB and soxS was detected in 2 and 9 isolates, respectively. The results of this study show a wide range of different mechanisms of fluoroquinolone resistance in E. coli isolates in Turkey.

🔖

Cite This Article

ERSOY, F., BÜYÜKCANGAZ, E., SONAL, S., ŞAHİNTÜRK, P., ARSLAN, E., ŞEN, A., CENGİZ, M., WEBBER, A. M., PIDDOCK, J. V. L. (2022). High level fluoroquinolone resistance in Escherichia coli isolatedfrom animals in Turkey is due to multiple mechanisms. Turkish Journal of Veterinary and Animal Sciences, Cilt: 40 - Sayı: 2, 214–218. https://ajindex.com/articles/615283

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Mavroidi A, Vivi M, Liakopoulos A, Tzelepi E, Stefos A, Dalekos, GN, Petinaki E. Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification. BMC Infect Dis 2012; 12: 371
  2. Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Ag 2005; 25: 358–373
  3. Hansen LH, Jensen LB, Sorensen HI, Sorensen SJ. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J Antimicrob Chemother 2007; 60: 145–147
  4. Yamane K, Wachino J, Suzuki S, Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 2008; 52: 1564–1566
  5. Wang M, Guo O, Xu X, Wang X, Ye X, Wu S, Hooper DC, Wang M. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob Agents Chemother 2009; 53: 1892–1897
  6. Bambeke FV, Pages JM, Lee VJ. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Pat Antiinfect Drug Discov 2006; 1: 157–175
  7. Webber M, Piddock LJV. Quinolone resistance in Escherichia coli. Vet Res 2001; 32: 275–284
  8. Nazik H, Ongen B, Kuvat N. Investigation of plasmid mediated quinolone resistance among isolates obtained in a Turkish intensive care unit. Jpn J Infect Dis 2008; 61: 310–312
  9. Barbour EK, Ahmadieh D, Harakeh S, Kumosani T. Impact of antimicrobials use in chickens on emergence of drug-resistant Campylobacter organisms in humans. Int J Antimicrob Ag 2012; 2: 1
  10. Clinical Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 6th ed. Approved Standard M7-A6. 2009; Wayne, PA, USA: CLSI; 2010
  11. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2014. Breakpoint tables for interpretation of MICs and zone diameters. Vaxjo, Sweden: EUCAST; 2014
  12. Adelowo OO, Fagade OE, Adelowo AY. Antibiotic resistance and resistance genes in Escherichia coli from poultry farms, southwest Nigeria. J Infect Dev Ctries 2014; 8: 1103–1112
  13. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC. qnr prevalence in ceftazidime-resistant Enterobacteriaceaeisolates from United States. Antimicrob Agents Chemother 2006; 50: 2872–2874
  14. Perichon B, Courvalin P, Galimand M. Transferable resistan